Literature DB >> 21960169

Transplant glomerulopathy: it's not always about chronic rejection.

Mark Haas.   

Abstract

Transplant glomerulopathy (TG) is a morphologic lesion of renal allografts characterized by duplication of the glomerular basement membrane and is widely accepted as a manifestation of chronic antibody-mediated rejection (AMR). However, TG is not specific for chronic AMR, and this pattern of injury may result from a number of disease processes affecting the glomerular endothelium. Baid-Agrawal and co-workers consider three different, but not mutually exclusive, processes that can produce morphologic lesions of TG: chronic AMR, hepatitis C, and thrombotic microangiopathy.

Entities:  

Mesh:

Year:  2011        PMID: 21960169     DOI: 10.1038/ki.2011.192

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  5 in total

1.  Acute transplant glomerulopathy with monocyte rich infiltrate.

Authors:  Colin R Lenihan; Jane C Tan; Neeraja Kambham
Journal:  Transpl Immunol       Date:  2013-09-19       Impact factor: 1.708

Review 2.  Rational clinical trial design for antibody mediated renal allograft injury.

Authors:  Shaifali Sandal; Martin S Zand
Journal:  Front Biosci (Landmark Ed)       Date:  2015-01-01

3.  Picking transplant glomerulopathy out of the CAN: evidence from a clinico-pathological evaluation.

Authors:  Qiquan Sun; Xianghua Huang; Song Jiang; Caihong Zeng; Zhihong Liu
Journal:  BMC Nephrol       Date:  2012-09-28       Impact factor: 2.388

4.  Development and validation of a prognostic index for allograft outcome in kidney recipients with transplant glomerulopathy.

Authors:  Pallavi Patri; Surya V Seshan; Marie Matignon; Dominique Desvaux; John R Lee; Jun Lee; Darshana M Dadhania; David Serur; Philippe Grimbert; Choli Hartono; Thangamani Muthukumar
Journal:  Kidney Int       Date:  2016-02       Impact factor: 10.612

5.  Poor Long-Term Renal Allograft Survival in Patients with Chronic Antibody-Mediated Rejection, Irrespective of Treatment-A Single Center Retrospective Study.

Authors:  Kaiyin Wu; Danilo Schmidt; Covadonga López Del Moral; Bilgin Osmanodja; Nils Lachmann; Qiang Zhang; Fabian Halleck; Mira Choi; Friederike Bachmann; Simon Ronicke; Wiebke Duettmann; Marcel G Naik; Eva Schrezenmeier; Birgit Rudolph; Klemens Budde
Journal:  J Clin Med       Date:  2021-12-30       Impact factor: 4.241

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.